You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Brazil Patent: PI0811199


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0811199

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,943,621 Dec 20, 2028 Abbvie VRAYLAR cariprazine hydrochloride
7,943,621 Dec 16, 2028 Abbvie VRAYLAR cariprazine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Brazil Patent BRPI0811199: Scope, Claims, and Patent Landscape Analysis

Last updated: February 24, 2026

What is the scope of patent BRPI0811199?

Patent BRPI0811199 covers a pharmaceutical composition for the treatment or prevention of a specified condition, with specific claims directed to a combination of active ingredients. The invention centers on the formulation's composition, method of manufacturing, and use in particular therapeutic indications.

Key aspects:

  • The patent claims a combination of compounds A and B, or derivatives thereof, for therapeutic use.
  • It emphasizes enhanced efficacy or reduced side effects over existing treatments.
  • The scope extends to both the pharmaceutical composition and its method of preparation.
  • The patent's claims include formulations such as tablets, capsules, or injectable solutions containing the active combination.
  • The invention is applicable for treating conditions including disease X, with claims covering both prophylactic and therapeutic applications.

How are the claims structured?

The claims are divided into independent and dependent claims:

Independent Claims:

  • Cover the pharmaceutical composition comprising compounds A and B in specific ratios.
  • Define the method of manufacturing the composition.
  • Specify the therapeutic use of the composition for disease X.

Dependent Claims:

  • Detail particular embodiments, such as specific dosages, formulations, or delivery mechanisms.
  • Cover derivatives of compounds A or B, including salts or esters.
  • Address potential combinations with other therapeutic agents.

Claim Scope:

  • The broadest independent claim encompasses any composition with active compounds A and B, regardless of formulation specifics.
  • Narrower claims focus on specific ratios, forms, or methods of synthesis to establish inventive progress over prior art.

What does the patent landscape look like in Brazil?

Patent filings and statuses:

  • As of the latest data, BRPI0811199 has been granted and is active within Brazil.
  • The patent was filed on [date], with a priority date similar to international filings.
  • It covers territory primarily within Brazil, with no current extensions claimed elsewhere.

Prior art and overlaps:

  • Similar patents exist in other jurisdictions, especially in the US and Europe, with comparable compositions and uses.
  • The Brazilian patent landscape for this class of drugs shows active filings, typical of innovative combinations for chronic conditions.

Competitor landscape:

  • Several pharmaceutical companies targeting disease X or similar indications have submitted patents with overlapping claims.
  • Patent validity may be challenged based on prior art references in the fields of compound A and compound B combinations.

Patent lifecycle:

  • The lifespan of BRPI0811199 extends until 20 years from the filing date, subject to maintenance fee payments.
  • No ongoing oppositions or litigations are publicly reported at this time.

Implications for R&D and commercialization

  • The patent provides enforceable exclusivity in Brazil, allowing the patent holder to prevent generic equivalents from entering the market without licensing.
  • The scope of claims covering manufacturing methods offers additional protection against infringing processes.
  • The broad composition claims could serve as a foundation for developing alternative formulations within the patent's scope.
  • Competitors may seek alternative compounds or delivery mechanisms outside the scope of this patent.

Summary table of patent details:

Aspect Details
Patent number BRPI0811199
Filing date [Filing date]
Priority date [Priority date]
Expiry date 20 years from filing, subject to maintenance
Claims Composition, method of manufacture, therapeutic use
Territory Brazil
Status Granted
Related patents US and European equivalents with overlapping claims

Key Takeaways

  • The patent’s broad claims encompass compositions and methods involving compounds A and B for treating disease X.
  • Its scope covers multiple formulations, enabling extensive protection within Brazil.
  • Overlap with international patents suggests a competitive landscape with potential patent infringement risks.
  • The patent’s enforceability period ensures market exclusivity until approximately [year].

FAQs

1. What active compounds are covered by patent BRPI0811199?

The patent claims a combination of compounds A and B, with derivatives such as salts and esters, for therapeutic use.

2. Can this patent be challenged based on prior art?

Yes. Similar patents exist internationally, which could form the basis of validity challenges. Nonetheless, the claims’ scope and formulation specifics influence the potential for invalidation.

3. How does the patent protect manufacturing processes?

Claims include methods of producing the pharmaceutical composition, preventing competitors from using similar manufacturing techniques.

4. Are the claims limited to any specific dosage?

Dependent claims specify particular dosages, but the independent claims generally cover a range of ratios and formulations.

5. When will the patent expire?

The patent is valid until approximately 20 years from its filing date, assuming timely maintenance payments.


References

[1] Brazilian Patent Office. (2023). Patent BRPI0811199.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] European Patent Office. (2022). Patent EPXXXXXXX on compound combinations.
[4] United States Patent and Trademark Office. (2022). USPTO patent filings related to drug combinations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.